{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T19:35:06Z","timestamp":1769283306686,"version":"3.49.0"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,3]]},"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Evidence has shown that angiotensin II type 1 receptor antagonists have lower blood pressure and have target organ protective effects, but this is not the case for the drug allisartan isoproxil. The aim of this study was to evaluate the effects of allisartan isoproxil on blood pressure and target organ injury in patients with mild to moderate essential hypertension.<\/jats:p>\n            <jats:p>In total, 80 essential hypertensive participants were randomly divided into an allisartan group and a nifedipine group (n\u200a=\u200a40 per group), and their blood pressure was measured once per month for 6 months. A 2-dimensional echocardiogram was performed at baseline and at the end of the study. The serum levels of renal injury indexes, endothelial function markers, inflammatory factors, blood biochemical assays and urinary measurements were determined at baseline and at 6 months.<\/jats:p>\n            <jats:p>At the end of the study, both systolic and diastolic blood pressure were significantly decreased in the allisartan group compared with baseline and showed the same antihypertensive effect as the nifedipine group. Meanwhile, the left ventricular remodeling, 24-hours levels of urinary microalbumin, endothelial dysfunction, and arterial stiffness were all significantly improved compared with that of the baseline and the nifedipine group (all <jats:italic toggle=\"yes\">P\u200a&lt;\u200a<\/jats:italic>.05).<\/jats:p>\n            <jats:p>The present study showed that allisartan isoproxil had favorable blood pressure lowering and heart, renal, and endothelial protective effects in patients with mild to moderate essential hypertension.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000014907","type":"journal-article","created":{"date-parts":[[2019,3,21]],"date-time":"2019-03-21T11:50:14Z","timestamp":1553169014000},"page":"e14907","source":"Crossref","is-referenced-by-count":14,"title":["Effects of allisartan isoproxil on blood pressure and target organ injury in patients with mild to moderate essential hypertension"],"prefix":"10.1097","volume":"98","author":[{"given":"Jian-Qi","family":"Zhang","sequence":"first","affiliation":[{"name":"Graduate School of Tianjin Medical University"},{"name":"Tianjin Key Laboratory of Cardiovascular Remodeling and Target Organ Injury, Pingjin Hospital Heart Center, Tianjin, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guo-Hong","family":"Yang","sequence":"additional","affiliation":[{"name":"Graduate School of Tianjin Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Zhou","sequence":"additional","affiliation":[{"name":"Graduate School of Tianjin Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-Xiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Shi","sequence":"additional","affiliation":[{"name":"Graduate School of Tianjin Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Dong","sequence":"additional","affiliation":[{"name":"Graduate School of Tianjin Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shao-Bo","family":"Chen","sequence":"additional","affiliation":[{"name":"Graduate School of Tianjin Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Ming","family":"Li","sequence":"additional","affiliation":[{"name":"Graduate School of Tianjin Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230914","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1161\/HYPERTENSIONAHA.117.10786","article-title":"Hypertension, microvascular pathology, and prognosis after an acute myocardial infarction","volume":"72","author":"Carrick","year":"2018","journal-title":"Hypertension"},{"key":"R2-20230914","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1161\/CIRCULATIONAHA.118.034168","article-title":"Association of urinary nitrate with lower prevalence of hypertension and stroke and with reduced risk of cardiovascular mortality","volume":"137","author":"Mendy","year":"2018","journal-title":"Circulation"},{"key":"R3-20230914","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/bcpt.12912","article-title":"The combination of valsartan and sacubitril in the treatment of hypertension and heart failure\u2014an update","volume":"122","author":"Nielsen","year":"2018","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"R4-20230914","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1093\/ajh\/hpx222","article-title":"Hypertension control in adults with CKD in China: baseline results from the Chinese Cohort Study of Chronic Kidney Disease (C-STRIDE)","volume":"31","author":"Yan","year":"2018","journal-title":"Am J Hypertens"},{"key":"R5-20230914","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1161\/CIR.0000000000000558","article-title":"Heart disease and stroke statistics\u20142018 update: a report from the American Heart Association","volume":"137","author":"Benjamin","year":"2018","journal-title":"Circulation"},{"key":"R6-20230914","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1016\/j.jacc.2017.11.005","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"71","author":"Whelton","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"R7-20230914","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/jhh.2015.125","article-title":"Combination therapy of renin-angiotensin system inhibitors plus calcium channel blockers versus other two-drug combinations for hypertension: a systematic review and meta-analysis","volume":"31","author":"Lu","year":"2017","journal-title":"J Hum Hypertens"},{"key":"R8-20230914","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/ajh\/hpx167","article-title":"Renin-angiotensin-aldosterone system parameters as biomarker in heart failure patients with preserved ejection fraction: focus on angiotensinogen","volume":"31","author":"Uijl","year":"2018","journal-title":"Am J Hypertens"},{"key":"R9-20230914","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jjcc.2016.03.012","article-title":"Clinical impacts of inhibition of renin-angiotensin system in patients with acute ST-segment elevation myocardial infarction who underwent successful late percutaneous coronary intervention","volume":"69","author":"Park","year":"2017","journal-title":"J Cardiol"},{"key":"R10-20230914","doi-asserted-by":"crossref","first-page":"6822","DOI":"10.1096\/fj.201800458","article-title":"Angiotensin II receptor I blockade prevents stenosis of tissue engineered vascular grafts","volume":"32","author":"Ruiz-Rosado","year":"2018","journal-title":"FASEB J"},{"key":"R11-20230914","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1161\/HYPERTENSIONAHA.118.10266","article-title":"Understanding angiotensin II type 1 receptor signaling in vascular pathophysiology","volume":"71","author":"Eguchi","year":"2018","journal-title":"Hypertension"},{"key":"R12-20230914","doi-asserted-by":"crossref","first-page":"63","DOI":"10.18565\/cardio.2016.6.63-67","article-title":"Prevention of cardiovascular complications in patients with arterial hypertension while use of angiotensin II receptor antagonists. Possibilities of candesartan","volume":"56","author":"Savina","year":"2016","journal-title":"Kardiologiia"},{"key":"R13-20230914","first-page":"27","article-title":"Angiotensin II type 1 receptor antagonists in the treatment of hypertension in elderly patients: focus on patient outcomes","volume":"2","author":"Tadevosyan","year":"2011","journal-title":"Patient Relat Outcome Meas"},{"key":"R14-20230914","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/aps.2009.11","article-title":"Effects of allisartan, a new AT(1) receptor blocker, on blood pressure and end-organ damage in hypertensive animals","volume":"30","author":"Wu","year":"2009","journal-title":"Acta Pharmacol Sin"},{"key":"R15-20230914","doi-asserted-by":"crossref","first-page":"619","DOI":"10.2165\/00044011-200424100-00008","article-title":"Pharmacokinetics of losartan and its active metabolite EXP3174 in healthy Iranian subjects","volume":"24","author":"Amini","year":"2004","journal-title":"Clin Drug Investig"},{"key":"R16-20230914","first-page":"1","article-title":"Effects of quercetin on the pharmacokinetics of losartan and its metabolite EXP3174 in rats","author":"Zhao","year":"2018","journal-title":"Xenobiotica"},{"key":"R17-20230914","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1080\/13880209.2016.1190762","article-title":"Effects of berberine on the pharmacokinetics of losartan and its metabolite EXP3174 in rats and its mechanism","volume":"54","author":"Li","year":"2016","journal-title":"Pharm Biol"},{"key":"R18-20230914","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/1076029617726600","article-title":"Discordance between VASP phosphorylation and platelet aggregation in defining high on-clopidogrel platelet reactivity after ST-segment elevation myocardial infarction","volume":"24","author":"Sun","year":"2018","journal-title":"Clin Appl Thromb Hemost"},{"key":"R19-20230914","doi-asserted-by":"crossref","first-page":"e0342","DOI":"10.1097\/MD.0000000000010342","article-title":"Effects of a low salt diet on isolated systolic hypertension: a community-based population study","volume":"97","author":"Yang","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"R20-20230914","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.echo.2007.02.034","article-title":"Devereux formula for left ventricular mass\u2014be careful to use the right units of measurement","volume":"20","author":"Jafary","year":"2007","journal-title":"J Am Soc Echocardiogr"},{"key":"R21-20230914","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1161\/01.STR.32.7.1520","article-title":"Accuracy of in vivo carotid B-mode ultrasound compared with pathological analysis: intima-media thickening, lumen diameter, and cross-sectional area","volume":"32","author":"Schulte-Altedorneburg","year":"2001","journal-title":"Stroke"},{"key":"R22-20230914","first-page":"77","article-title":"Lower ankle-brachial index is associated with poor sleep quality in patients with essential hypertension","volume":"5","author":"Yamaki","year":"2015","journal-title":"Am J Cardiovasc Dis"},{"key":"R23-20230914","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/ajh.2011.19","article-title":"Brachial-ankle pulse wave velocity predicts increase in blood pressure and onset of hypertension","volume":"24","author":"Takase","year":"2011","journal-title":"Am J Hypertens"},{"key":"R24-20230914","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4103\/1117-1936.163631","article-title":"Clinical usefulness of a timed overnight (8\u200ahours) Urine Albumin (microalbumin) excretion in monitoring treatment in benign essential hypertension","volume":"21","author":"Oluwatowoju","year":"2014","journal-title":"Niger Postgrad Med J"},{"key":"R25-20230914","first-page":"144","article-title":"Concentration of BNP, endothelin 1, pro-inflammatory cytokines (TNF-alpha, IL-6) and exercise capacity in patients with heart failure treated with carvedilol","volume":"66","author":"Nessler","year":"2008","journal-title":"Kardiol Pol"},{"key":"R26-20230914","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1161\/CIRCULATIONAHA.111.070680","article-title":"Epoxyeicosatrienoic acids contribute with altered nitric oxide and endothelin-1 pathways to conduit artery endothelial dysfunction in essential hypertension","volume":"125","author":"Bellien","year":"2012","journal-title":"Circulation"},{"key":"R27-20230914","first-page":"51","article-title":"How to calculate sample size in randomized controlled trial?","volume":"1","author":"Zhong","year":"2009","journal-title":"J Thorac Dis"},{"key":"R28-20230914","first-page":"10428","article-title":"Losartan alleviates hyperuricemia-induced atherosclerosis in a rabbit model","volume":"8","author":"Zheng","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"R29-20230914","first-page":"174","article-title":"Clinical study of double dose of valsartan combined with tacrolimus in treatment of diabetic nephropathy","volume":"20","author":"Jin","year":"2016","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R30-20230914","doi-asserted-by":"crossref","first-page":"9040457","DOI":"10.1155\/2016\/9040457","article-title":"Ramipril and losartan exert a similar long-term effect upon markers of heart failure, endogenous fibrinolysis, and platelet aggregation in survivors of ST-elevation myocardial infarction: a single centre randomized trial","volume":"2016","author":"Marinsek","year":"2016","journal-title":"Biomed Res Int"},{"key":"R31-20230914","doi-asserted-by":"crossref","first-page":"e0117560","DOI":"10.1371\/journal.pone.0117560","article-title":"A randomized, double blind, placebo-controlled, multicenter phase II trial of Allisartan Isoproxil in essential hypertensive population at low-medium risk","volume":"10","author":"Li","year":"2015","journal-title":"PLoS One"},{"key":"R32-20230914","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1097\/HJH.0000000000000614","article-title":"Effects of blood pressure-lowering on outcome incidence in hypertension: 5. Head-to-head comparisons of various classes of antihypertensive drugs - overview and meta-analyses","volume":"33","author":"Thomopoulos","year":"2015","journal-title":"J Hypertens"},{"key":"R33-20230914","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1016\/j.jacc.2003.12.051","article-title":"Comparative effects of valsartan versus amlodipine on left ventricular mass and reactive oxygen species formation by monocytes in hypertensive patients with left ventricular hypertrophy","volume":"43","author":"Yasunari","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"R34-20230914","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2459\/JCM.0b013e3283511f00","article-title":"The effect of valsartan on left ventricular myocardial functions in hypertensive patients with left ventricular hypertrophy","volume":"13","author":"Kucukler","year":"2012","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"R35-20230914","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/j.jacc.2003.12.053","article-title":"Severity of left ventricular remodeling defines outcomes and response to therapy in heart failure: valsartan heart failure trial (Val-HeFT) echocardiographic data","volume":"43","author":"Wong","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"R36-20230914","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1097\/HJH.0000000000001547","article-title":"Effects of blood-pressure-lowering treatment on outcome incidence. 12. Effects in individuals with high-normal and normal blood pressure: overview and meta-analyses of randomized trials","volume":"35","author":"Thomopoulos","year":"2017","journal-title":"J Hypertens"},{"key":"R37-20230914","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1097\/HJH.0b013e328351856d","article-title":"Prevention of microalbuminuria in patients with type 2 diabetes and hypertension","volume":"30","author":"Menne","year":"2012","journal-title":"J Hypertens"},{"key":"R38-20230914","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1161\/01.CIR.0000146378.65439.7A","article-title":"Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria","volume":"110","author":"Asselbergs","year":"2004","journal-title":"Circulation"},{"key":"R39-20230914","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1161\/01.HYP.35.1.501","article-title":"Effect of the angiotensin II type 1 receptor blocker candesartan on endothelial function in patients with essential hypertension","volume":"35","author":"Ghiadoni","year":"2000","journal-title":"Hypertension"},{"key":"R40-20230914","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1093\/ajh\/hpt208","article-title":"Effects of an angiotensin II receptor blocker on the impaired function of endothelial progenitor cells in patients with essential hypertension","volume":"27","author":"Suzuki","year":"2014","journal-title":"Am J Hypertens"},{"key":"R41-20230914","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1097\/00004872-199715022-00009","article-title":"Large artery stiffness in hypertension","volume":"15","author":"Benetos","year":"1997","journal-title":"J Hypertens Suppl"},{"key":"R42-20230914","doi-asserted-by":"crossref","first-page":"132","DOI":"10.4103\/jcecho.jcecho_43_17","article-title":"Carotid artery stiffness and development of hypertension in people with paraplegia and no overt cardiovascular disease: a 7-year follow-up study","volume":"27","author":"Vriz","year":"2017","journal-title":"J Cardiovasc Echogr"},{"key":"R43-20230914","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/ncpcardio0307","article-title":"Large-artery stiffness, hypertension and cardiovascular risk in older patients","volume":"2","author":"Blacher","year":"2005","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"R44-20230914","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3317\/jraas.2000.009","article-title":"Reduction of resistance artery stiffness by treatment with the AT(1)-receptor antagonist losartan in essential hypertension","volume":"1","author":"Park","year":"2000","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"R45-20230914","doi-asserted-by":"crossref","first-page":"487.e1","DOI":"10.1016\/j.ahj.2010.05.037","article-title":"Protective effects of the angiotensin II receptor blocker telmisartan on epirubicin-induced inflammation, oxidative stress, and early ventricular impairment","volume":"160","author":"Cadeddu","year":"2010","journal-title":"Am Heart J"},{"key":"R46-20230914","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.amjcard.2015.02.005","article-title":"Relation of reduced preclinical left ventricular diastolic function and cardiac remodeling in overweight youth to insulin resistance and inflammation","volume":"115","author":"Dahiya","year":"2015","journal-title":"Am J Cardiol"},{"key":"R47-20230914","doi-asserted-by":"crossref","first-page":"E1366","DOI":"10.1152\/ajpendo.00478.2009","article-title":"Attenuation of diabetes-induced renal dysfunction by multiple exposures to low-dose radiation is associated with the suppression of systemic and renal inflammation","volume":"297","author":"Zhang","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R48-20230914","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.mehy.2004.10.016","article-title":"Inflammation may be a bridge connecting hypertension and atherosclerosis","volume":"64","author":"Li","year":"2005","journal-title":"Med Hypotheses"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00005792-201903220-00032","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T19:19:48Z","timestamp":1694719188000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201903220-00032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":48,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000014907","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3]]}}}